专利、商标和外观设计
我们帮助各种形式和规模的个人和企业
施利希是一个独特的欧洲专利和商标律师团队,总部位于英格兰南部。自2004年以来,我们帮助客户收购和保护他们的知识产权资产,帮助他们在知识产权资产的基础上建立和发展成功的企业。
我们起草和提交专利申请,使其获得批准并实施强制执行。我们还准备和提交商标申请,并为其注册进行起诉。
T为了执行客户的权利,我们还代表他们参加法院和其他各方之间的诉讼程序(必要时,提出异议和撤销竞争对手的权利)。
近期案例解析
阅读施利希团队关于涉及专利、商标和外观设计的近期真实案例解析和新闻动态。
Equivalence Explained – The Court of Appeal Provides Guidance on How to Correctly Apply the Actavis Test
In the case of Salts v Pelican, the UK Court of Appeal has provided helpful guidance on how to correctly apply the Actavis test when considering infringement under the doctrine of equivalents. This case appears to establish an important precedent for the application of this test to other cases in the future.
Teva v Eli Lilly: a different route for antibody genus claims?
Broad antibody claims have faced a difficult path in the US since Amgen v Sanofi, particularly where the claim covers a large functional genus. The Federal Circuit’s decision in Teva v Eli Lilly is therefore interesting because the court drew an important distinction: claims to antibodies themselves are not necessarily treated the same way as claims to methods of treatment using a known class of antibodies.
When Fame Backfires: Titles of George Orwell’s Best-Selling Novels Ruled to Lack Distinctiveness as a Result of their Fame
The recent decision of the Grand Board on the registrability of the titles of George Orwell’s most famous novels, “ANIMAL FARM” and “1984”, provides a long-awaited answer to the previously unresolved question of whether the titles of well-known books, films and other creative works can be protected as trade marks in Europe (and, to cut a long story short, the answer is no!).
G 1/26: The EPO’s Unfinished Business on Claim Interpretation
Following G 1/24, which held that the description must always be consulted when interpreting claims for patentability, a new referral to the Enlarged Board of Appeal - G 1/26 - asks whether that same approach applies more broadly, including to added matter, and whether the description can go beyond merely explaining claim terms to actually influence their meaning.
Watch Out for Bad Faith – Breitling for Women
The recent dispute between Iron & Smith Kft. and Breitling SA at the EUIPO Court of Appeal serves as a further example of how bad faith can be relied upon a ground for invalidity.
From EPO to UPC: The Lasting Impact of Prosecution on Claim Interpretation
The UPC continues to develop its approach to claim interpretation, particularly regarding the role of Patentee’s statements made during prosecution. A recent decision from the Milan Local Division in Agathon v. Intercom and Knarr offers insight into how the UPC treats such statements when construing patent claims.
By Touatis! “Obelix®” Has A Reputation
Asterix® and his best friend Obelix® are, of course, indomitable. Furthermore, Obelix’s name has a reputation across the European Union (EU) as confirmed by the EU General Court in case T‑24/25.
First UPC Referral to the CJEU: Just How Long is the Long-Arm Jurisdiction of the UPC?
In its first ever referral to the CJEU, the UPC seeks clarification over its jurisdiction to decide on infringement of European patents in EU Member States that chose not to sign up to the UPC Agreement.
在专利和商标法方面的卓越表现
施利希团队
由于施利希经验丰富的专业团队,我们的客户获得了超越期望值的迅速回馈,高质量和高价值的友好服务。我们的英国和欧洲专利律师以及特许商标律师,拥有英国顶尖大学的广泛科学和技术专业学位和博士学位,并在法律和商业问题及技术的最前沿拥有几十年的咨询经验。
我们在起诉和跨部门诉讼方面积累了深厚的经验,为客户的创新成果提供最佳的战略和实践建议,并确保最佳的专利和商标保护。我们的团队在更多高技能和经验丰富的法律支持人员团队的支持下,以友好和明确的方式高效地完成了每项诉讼事务。
最近公司动态
Schlich listed as one of Financial Times’ Leading Patent Law Firms in Europe for 2026
We are delighted to report that Schlich has, once again, been included in the Financial Time’s Europe’s Leading Patent Law Firms rankings for 2026.
Schlich recognised in IAM Patent 1000 rankings for 2026
We are pleased to announce that Schlich has once again been recognised in the IAM Patent 1000 rankings, for patent prosecution in the United Kingdom.
Schlich’s Reception Aboard the Golden Hinde
On Sunday, 3 May 2026 we were delighted to host our 2026 Schlich Reception, welcoming our clients, colleagues and friends from all around the world to London.







